Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,340 | 3 | 49.5% |
| Current or prospective ownership or investment interest | $7,313 | 8 | 49.3% |
| Food and Beverage | $189.97 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Esaote North America, Inc. | $7,313 | 8 | $0 (2018) |
| Novo Nordisk Inc | $4,840 | 1 | $0 (2018) |
| Janssen Research & Development, LLC | $2,500 | 2 | $0 (2021) |
| ZOLL Circulation Inc | $140.00 | 1 | $0 (2020) |
| revo Biologics, Inc. | $27.21 | 1 | $0 (2017) |
| Meditrina | $22.76 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $22.76 | 1 | Meditrina ($22.76) |
| 2021 | $2,500 | 2 | Janssen Research & Development, LLC ($2,500) |
| 2020 | $140.00 | 1 | ZOLL Circulation Inc ($140.00) |
| 2018 | $5,619 | 2 | Novo Nordisk Inc ($4,840) |
| 2017 | $6,561 | 8 | Esaote North America, Inc. ($6,534) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2023 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $22.76 | General |
| 03/24/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 03/01/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 03/05/2020 | ZOLL Circulation Inc | Temperature Management System (Device), Catheter, Temperature Management System Start-Up Kit | Food and Beverage | Cash or cash equivalent | $140.00 | General |
| Category: Temperature Management | ||||||
| 07/30/2018 | Novo Nordisk Inc | NovoSeven RT (Drug) | Consulting Fee | Cash or cash equivalent | $4,840.00 | General |
| Category: Hemophilia | ||||||
| 01/01/2018 | Esaote North America, Inc. | Probe, AC2541 Abdominal (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $778.75 | General |
| Category: Ultrasound Related Device | ||||||
| 12/31/2017 | Esaote North America, Inc. | PROBE,CA631 (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $1,534.00 | General |
| Category: Ultrasound-related device | ||||||
| 12/31/2017 | Esaote North America, Inc. | PROBE,CA631 (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $1,534.00 | General |
| Category: Ultrasound-related device | ||||||
| 12/31/2017 | Esaote North America, Inc. | PROBE,LA332E (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $1,325.00 | General |
| Category: Ultrasound-related device | ||||||
| 12/31/2017 | Esaote North America, Inc. | PROBE,AC2541 ABDOMINAL (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $902.00 | General |
| Category: Ultrasound-related device | ||||||
| 12/31/2017 | Esaote North America, Inc. | ROLL STAND, MLALPHA (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $375.00 | General |
| Category: Ultrasound-related device | ||||||
| 10/23/2017 | Esaote North America, Inc. | ROLL STAND, MLALPHA (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $304.00 | General |
| Category: Ultrasound-related device | ||||||
| 05/19/2017 | Esaote North America, Inc. | PROBE,AC2541 ABDOMINAL (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $560.00 | General |
| Category: Ultrasound-related device | ||||||
| 01/27/2017 | revo Biologics, Inc. | ATryn (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Not Applicable | ||||||
About Dr. Michael Paidas, MD
Dr. Michael Paidas, MD is a Maternal & Fetal Medicine healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821071994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Paidas, MD has received a total of $14,843 in payments from pharmaceutical and medical device companies, with $22.76 received in 2023. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($7,340).
Practice Information
- Specialty Maternal & Fetal Medicine
- Other Specialties Obstetrics & Gynecology
- Location Miami, FL
- Active Since 11/22/2005
- Last Updated 12/22/2025
- Taxonomy Code 207VM0101X
- Entity Type Individual
- NPI Number 1821071994
Products in Payments
- NovoSeven RT (Drug) $4,840
- PROBE,CA631 (Device) $3,068
- PROBE,AC2541 ABDOMINAL (Device) $1,462
- PROBE,LA332E (Device) $1,325
- Probe, AC2541 Abdominal (Device) $778.75
- ROLL STAND, MLALPHA (Device) $679.00
- Temperature Management System (Device) $140.00
- ATryn (Drug) $27.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Maternal & Fetal Medicine Doctors in Miami
Dr. Lesley De La Torre, D.o, D.O
Maternal & Fetal Medicine — Payments: $620.36
Felipe Tudela, M.d, M.D
Maternal & Fetal Medicine — Payments: $311.97
Maria Teresa Mella, Md, MD
Maternal & Fetal Medicine — Payments: $170.15
Dr. Liviu Cojocaru, M.d, M.D
Maternal & Fetal Medicine — Payments: $151.62
Dr. Makbib Diro, Md, MD
Maternal & Fetal Medicine — Payments: $92.73
Gene Burkett, Md, MD
Maternal & Fetal Medicine — Payments: $23.04